FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns an agent possessing cerebral-protective, endothelial-positive and antithrombotic effect in the conditions of ishemic cerebral circulation disorder, containing 4-amino-3-phenylbutane acid, L-arginine hydrochloride and salicylic acid in the molar ratio of 1:1:1.
EFFECT: invention provides low-toxic agent possessing cerebral-protective, endothelial-positive and antithrombotic effect in the conditions of ishemic cerebral circulation disorder.
1 cl, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
| AGENT FOR PRESERVING POPULATION OF GABA-ERGIC NEURONS AFTER ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672884C1 |
| 4-(4-ACETOXYBENZOYLAMINO)BUTANOYLGLYCINE, WHICH HAS A CEREBROPROTECTIVE ACTION IN CEREBRAL ISCHEMIA | 2017 |
|
RU2657820C1 |
| (2S,4S)-4-AMINO-N-(4-FLUOROPHENYL)PYROGLUTAMIC ACID EXHIBITING CEREBROPROTECTIVE, NOOTROPIC, AND ANTITHROMBOTIC ACTION | 2021 |
|
RU2769521C1 |
| AGENT POSSESSING ENDOTHELIUM PROTECTIVE EFFECT IN CONDITIONS OF EXPERIMENTAL DIABETES MELLITUS AND CEREBRAL BLOOD CIRCULATION DISORDER | 2015 |
|
RU2601622C1 |
| AGENT HAVING A PROPERTY TO PREVENT DEATH OF GABA-ERGIC NEURONS IN CONDITIONS OF ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672918C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| NEW WATER-SOLUBLE SALICYLAMIDE DERIVATIVE WITH NEUROPROTECTIVE ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2017 |
|
RU2641102C1 |
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
